JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M108966200 on December 17, 2001

J. Biol. Chem., Vol. 277, Issue 8, 6153-6161, February 22, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/8/6153    most recent
M108966200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindahl, G. E.
Right arrow Articles by Laurent, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindahl, G. E.
Right arrow Articles by Laurent, G. J.

Activation of Fibroblast Procollagen alpha 1(I) Transcription by Mechanical Strain Is Transforming Growth Factor-beta -dependent and Involves Increased Binding of CCAAT-binding Factor (CBF/NF-Y) at the Proximal Promoter*

Gisela E. LindahlDagger §, Rachel C. ChambersDagger , Jenny PapakrivopoulouDagger , Sally J. Dawson, Marianne C. JacobsenDagger , Jill E. BishopDagger , and Geoffrey J. LaurentDagger

From the Dagger  Centre for Cardiopulmonary Biochemistry and Respiratory Medicine, Department of Medicine, Royal Free and University College Medical School, The Rayne Institute, 5 University Street, London WC1E 6JJ and  Molecular Audiology, Department of Immunology and Molecular Pathology, Windeyer Institute, Royal Free and University College Medical School, 46 Cleveland St., London W1T 4JF, United Kingdom

Received for publication, September 17, 2001, and in revised form, December 7, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

During normal developmental tissue growth and in a number of diseases of the cardiopulmonary system, adventitial and interstitial fibroblasts are subjected to increased mechanical strain. This leads to fibroblast activation and enhanced collagen synthesis, but the underlying mechanisms involved remain poorly understood. In this study, we have begun to identify and characterize mechanical strain-responsive elements in the rat procollagen alpha 1(I) (COL1A1) gene and show that the activity of COL1A1 promoter constructs, transiently transfected into cardiac fibroblasts, was increased between 2- and 4-fold by continuous cyclic mechanical strain. This was accompanied by a ~3-fold increase in the levels of total active transforming growth factor-beta (TGF-beta ) released into the medium. Inclusion of a pan-specific TGF-beta neutralizing antibody inhibited strain-induced COL1A1 promoter activation. Deletion analysis revealed the presence of two potential strain response regions within the proximal promoter, one of which contains an inverted CCAAT-box overlapping a GC-rich element. Both mechanical strain and exogenously added TGF-beta 1 enhanced the binding activity of CCAAT-binding factor, CBF/NF-Y, at this site. Moreover, this element was sufficient to confer strain-responsiveness to an otherwise unresponsive SV40 promoter. In summary, this study demonstrates that strain-induced COL1A1 promoter activation in cardiac fibroblasts is TGF-beta -dependent and involves increased binding of CCAAT-binding factor at the proximal promoter. Furthermore, these findings suggest a novel and potentially important TGF-beta response element in the rat COL1A1 gene.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cells of the cardiopulmonary system are constantly exposed to mechanical stimulation from shear and tensile stresses, and in a number of pathological states, e.g. systemic hypertension, these stresses are significantly exaggerated (1). There is increasing evidence that mechanical strain plays an important role in maintaining normal tissue architecture by influencing cell function and behavior and may also be involved in the pathogenesis of disease (2). This area of research has recently gained much interest with respect to tissue remodeling seen in fibrosis and tissue repair in major organs, including the heart and lung, because increased mechanical force (strain, shear stress, and pressure) has been shown to activate a multitude of intracellular signaling pathways and alter the expression of a large number of genes in cells from these organs (1, 3). In the cardiopulmonary system, interstitial fibroblasts are believed to play a central role in orchestrating tissue remodeling in response to mechanical strain, both by increasing the release of auto/paracrine factors leading to proliferation and by altering their expression of extracellular matrix genes (1).

Type I collagen, the most abundant protein in the interstitium of major organs, plays a critical structural role and influences numerous cellular responses (4). Excessive production of type I collagen is a key feature of fibrotic disorders of the lung, liver, kidney, skin, and heart and multisystem diseases such as systemic sclerosis and hypertension, often leading to severe organ dysfunction (5-7). Novel therapeutic approaches for these disorders will come from a thorough understanding of the molecular mechanisms involved in the regulation of the type I collagen genes in such pathological conditions. The expression of the genes COL1A1 and COL1A2, encoding the alpha 1 and alpha 2 chains of type I collagen, respectively, is controlled primarily at the level of transcription and is tightly regulated to allow physiologic modulation during development and tissue repair (8, 9). Numerous mediators, including transforming growth factor-beta (TGF-beta ),1 connective tissue growth factor, insulin-like growth factor-I, prostaglandine-E2, and interferon-gamma , have been shown to up- or down-regulate type I collagen gene expression in vitro. Moreover, changes in the relative levels of these mediators have been associated with fibrotic disorders (4). TGF-beta 1, a member of a family of cytokines with pleiotropic effects on fibroblasts, has emerged as a pivotal mediator in tissue repair (10) and in the development of fibrosis (11, 12) and is the most potent inducer of procollagen I gene expression characterized to date (4).

The role of TGF-beta in pressure overload-induced cardiac fibrosis is currently being explored. It was recently reported that transforming-growth factor-beta -activated kinase, TAK1, a mediator of TGF-beta signaling, is activated as a delayed response to mechanical stress in mouse myocardium. Furthermore, a constitutively active form of TAK1 expressed in the mouse heart was sufficient to cause cardiac hypertrophy, interstitial fibrosis, and severe myocardial dysfunction (13). We and others have shown that increased mechanical load enhances the expression of the COL1A1 gene both in vivo (1) and in isolated fibroblasts in vitro (14); however, the underlying molecular mechanisms leading to this change remain poorly understood. There is evidence from studies in mesangial (15) and smooth muscle cells (16) that enhanced COL1A1 expression in response to mechanical strain is TGF-beta -dependent. Increased activation of TGF-beta has also been demonstrated for fibroblasts subjected to strain (17); however, whether this was sufficient to cause an increase in COL1A1 expression was not examined.

A major TGF-beta 1 response element has been reported at position -1624 in the rat COL1A1 gene (18), but the functional importance of this site has subsequently been questioned (19). Moreover, results from two studies, including the original report, suggest the existence of other, as yet unidentified, response elements (18, 20). Several additional regulatory elements and their cognate transcription factors have been implicated in TGF-beta transactivation of type I collagen genes in other species. Because of the high sequence homology in certain regions of the type I collagen promoters across species, these elements may represent potential additional candidates for mediating the response to TGF-beta and mechanical strain in the rat COL1A1 gene. These elements have been shown to bind transcription factors Sp1, NF-I, and AP1 (1), and more recently also Smad proteins (21), the major effector molecules responsible for propagating TGF-beta signaling following receptor activation (22). Early activation of the human procollagen alpha 2(I) (COL1A2) gene by TGF-beta was shown to involve interaction of Smad3/Smad4 with Sp1 in both fibroblasts (23) and mesangial cells (24). Smad proteins can also interact with components of the AP1 complex, as has been demonstrated in the activation of the collagenase I promoter (25). In addition, there is accumulating evidence that Smad3 plays a major role in mediating the fibrotic responses of TGF-beta (26), but whether Smad complexes are directly involved in the activation of the type I collagen genes during prolonged cellular stress leading to fibrosis remains to be established.

With this background we hypothesized that transcriptional activation of the rat COL1A1 gene in cardiac fibroblasts subjected to mechanical strain is mediated by autocrine stimulation by TGF-beta and that this activation involves TGF-beta response elements in the promoter region of the gene. To address this hypothesis, rat cardiac fibroblasts were transiently transfected with rat COL1A1 promoter/reporter gene constructs and subjected to mechanical strain. Here we show that cyclic mechanical strain activates the rat COL1A1 promoter in cardiac fibroblasts via a TGF-beta -dependent pathway. Furthermore, at least two regions in the proximal promoter, including an inverted CCAAT-box at position -100/-94, appear to be involved in the response. Finally, increased binding of CBF/NF-Y to this inverted CCAAT-box was shown to contribute to the transcriptional activation by mechanical strain. These findings have important implications for our understanding of the mechanism by which mechanical force increases COL1A1 gene activation. Importantly, these findings identify an as yet unappreciated role for CBF/NF-Y in regulating COL1A1 transcription in response to extracellular signals associated with enhanced extracellular matrix deposition.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture and Cyclic Mechanical Strain Applied to Fibroblasts-- Primary cultures of fetal Sprague-Dawley rat cardiac fibroblasts were prepared by collagenase digestion as previously described (27), and maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, 2 mM glutamine, and antibiotics (Invitrogen). Cells were used at passages 6-9 and plated on collagen I-coated elastic silicon membranes in 6-well (25-mm diameter) Flex I plates (FlexCell International). Confluent cells were preincubated in serum-free DMEM containing serum replacement 1 and HEPES buffer (Sigma), glutamine, and antibiotics. After 24 h, the medium was replaced with fresh serum-free medium, either alone or supplemented with either 50 ng/ml mithramycin (Sigma), 1 ng/ml porcine TGF-beta 1 (R&D Systems), 75 µg/ml pan-specific TGF-beta neutralizing antibody (AB-100-NA, R&D Systems, which, according to the manufacturer, was sufficient to block 90% of the effect of 1 ng/ml TGF-beta 1), or equivalent amounts of IgG control antibody. The TGF-beta neutralizing antibody and mithramycin was added 1 h prior to subjecting the cells to mechanical strain. The cells were subjected to mechanical strain for 24-48 h using the Flexercell FX-3000 apparatus (Flexcell International), which applies controlled cyclic or static strain to cell monolayers in culture. The strain applied was such as to give an average of 10% elongation of the membrane and a cycle frequency of 1 Hz. This strain regimen was chosen because it is similar to physiological/pathological tension experienced by cells in the heart (28).

Plasmids and Generation of 5' Deletion Constructs-- pColCAT3.6/1.6 (also denoted B16) was a gift from A. Lichtler and D. Rowe (University of Connecticut Health Center). This plasmid construct is identical to B15, described by Breault et al. (29), except an EcoRV site in the polylinker has been converted to a ClaI site. The construct contains sequences between -3518 and +1594 (relative to the transcription start site) of the rat COL1A1 gene, which includes the upstream promoter region, the first exon (the translational start site, ATG, has been converted to a NotI site), and most of the first intron (3.6/1.6 refers to 3.6 kb of upstream promoter sequence and 1.6 kb of downstream sequence). To create the promoter deletion constructs pCOLCAT-1.3/1.6 and -0.4/1.6, B16 was digested with NheI (all restriction enzymes were purchased from MBI Fermentas) at position -3382, together with Tth111I at -1282 to create pColCAT-1.3/1.6, or MunI at -395 to create pColCAT-0.4/1.6. The ends were blunted and the constructs religated. The intronless pColCAT3.6/0 has the first intron and the distal third of the first exon replaced with the 16 S splice donor site from the SV40 virus (compare B47 in Ref. 29). The set of proximal promoter deletion constructs were generated using an ExoIII/Mung Bean deletion kit (Stratagene) following the manufacturer's recommendations. MunI restriction enzyme was used to linearize B16 after which exonuclease treatment generated small deletions of various lengths in both directions. The constructs were subsequently digested with NheI and religated to generate promoter fragments with different 5' ends but which were ligated to an identical upstream cloning site, equivalent to that of constructs pCOLCAT-1.3/1.6 and -0.4/1.6. The exact extent of the deletions and the sequence across cloning sites were determined by automated DNA sequencing (377 DNA Sequencer, Applied Biosystems) using the Dye Terminator Cycle Sequencing Kit (Amersham Biosciences). The sequence numbering in the proximal promoter is according to the rat COL1A1 promoter sequence reported by Lichtler et al. (30) (GenBankTM accession number J04464). The heterologous promoter constructs were generated by ligating double-stranded oligonucleotides containing the wild-type or mutated Region A sequence (Fig. 4A), with additional restriction enzyme sites at either end, to the SV40 promoter-driven (enhancer-less) luciferase pGL2P vector (Promega). The correct sequence was confirmed by DNA sequencing as described above.

Transcient Transfections and Promoter Activity Assays-- Transfections of rat COL1A1 promoter-reporter constructs into rat cardiac fibroblasts (at ~90% confluence) were performed using the calcium phosphate ProFection Mammalian Transfection System (Promega) according to the manufacturer's recommendations 3 h after the addition of fresh serum-containing medium. At least two different plasmid DNA preparations (EndoFree, Qiagen) were tested to eliminate potential preparation artifacts. Cells were transfected with 0.5 µg of DNA per well (25-mm diameter) overnight (16 h), rinsed twice with phosphate-buffered saline and then treated as described above. At the appropriate time points, the cells were lysed and luciferase activity measured as chemiluminescence in a TD-20/20 luminometer from Turner designs (Promega) using the Luciferase Assay System (Promega). The data are presented as relative light units (RLU). Chloramphenicol acetyl transferase (CAT) protein levels in the cell lysates were measured by ELISA (Roche Molecular Biochemicals), were within the linear range of the standard curve and expressed as relative absorbance units (RAU). Because many viral promoters driving reporter genes in transfection control plasmids are regulated by mechanical strain (personal observation), a Hirt's assay was performed as described in Clark et al. (31) to determine the relative transfection efficiency between constructs used and between experimental conditions. Briefly, a DNA fragment from the vector backbone part of the COL1A1 promoter/reporter construct was radiolabeled and used as a probe in hybridizations to DNA from 30 µl of cell lysate that had been denatured and immobilized on a nylon membrane. The relative radioactive signal representing the amount of plasmid DNA in the cell lysate was measured by phosphorimaging densitometry. No significant difference in transfection efficiency was observed between the constructs or between experimental conditions. Transfections were performed three or more times in triplicate wells, unless otherwise indicated in the figure legends. Because the study was performed using primary fibroblasts and significant variation was observed in the fold induction of promoter activity between experiments, the data presented are from one representative experiment showing mean and standard error within that experiment. The statistical significance of the data was, however, evaluated by the Mann-Whitney U test of combined experiments.

TGF-beta Bioassay-- Levels of total active TGF-beta in the conditioned medium was determined using the method developed by Abe et al. (32). This assay is based on the capability of TGF-beta to induce plasminogen activator inhibitor-1 (PAI-1) expression and uses mink lung epithelial cells (Mv1Lu) stably transfected with a truncated PAI-1 promoter fused to the firefly luciferase reporter gene. Porcine TGF-beta 1 (R&D Systems) was used to generate a standard curve for the estimation of active TGF-beta concentrations in the medium. The statistical significance was evaluated by the Mann-Whitney U test using the raw data (relative luciferase activity).

Preparation of Nuclear Extracts and Electrophoresis Mobility Shift Assays (EMSA)-- Nuclear extracts were prepared according to the method of Schreiber et al. (33) from mechanically strained and rigid rat cardiac fibroblasts that had been pooled from six wells. Briefly, dishes were placed on ice and the cells washed twice with ice-cold Tris-buffered saline without Ca2+ and Mg2+. Nuclear proteins were extracted in 20 mM HEPES (pH 7.9), 400 mM NaCl, 1mMEGTA, 1 mM EDTA, 1 mM dithiothreitol, and protease inhibitor mixture (CompleteTM, Roche Diagnostics). The concentration was determined by the BCA protein assay (Pierce). Extracts were stored in aliquots at -80 °C prior to use and only freeze-thawed once. EMSAs, using radiolabeled probes, were performed essentially as described previously (34) with 3 µg of nuclear extract per binding reaction using standard conditions of a gel-shift kit from Promega. For competition assays, 125-fold molar excess of unlabeled oligonucleotides were added to the binding reaction 15 min prior to the addition of the labeled oligonucleotide. The oligonucleotides used are listed in Fig. 4A and were purchased from Invitrogen when custom made and Santa Cruz Biotechnology for standard transcription factor consensus binding sites. Antibody supershift assays were performed using anti-CBF-A or anti-NF-1 antibodies (Santa Cruz Biotechnology) or nonimmune IgG control antibodies added to the nuclear extracts and incubated for 30 min at room temperature prior to the addition of labeled oligonucleotides. The protein/DNA complexes were separated in a 4% acrylamide/bis (29:1) gel in 1× Tris borate/EDTA buffer. The relative intensities of the complex bands were calculated from the radioactive signal measured by phosphorimaging densitometry.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cyclic Mechanical Strain of Cardiac Fibroblasts Leads to Transactivation of the Rat COL1A1 Promoter-- Previous work has shown that COL1A1 mRNA levels are increased in rat cardiac fibroblasts subjected to mechanical strain (14). To begin to elucidate the transcriptional mechanisms involved, we initially used four rat COL1A1 promoter CAT-reporter constructs in transient transfection assays and exposed rat cardiac fibroblasts to continuous cyclic mechanical stretch (strain) for 48 h. All responses were compared with cells transfected with the same construct, but kept static under otherwise identical conditions (rigid controls) (Fig. 1). The full-length construct, pColCAT-3.6/1.6, contains 3.6 kb of the 5' upstream promoter sequence and 1.6 kb of sequence downstream of the transcription start site, including the first exon and most of the first intron. This construct was chosen because these regions of the COL1A1 gene, including the first intron, are known to contain potentially important positive and negative regulatory sequences (29, 35-37), and it therefore provides a suitable starting point for modeling responses of the endogenous gene. Cells transfected with the full-length pColCAT-3.6/1.6 construct displayed an ~2-fold increase in CAT protein levels in response to continuous cyclic strain for 48 h compared with rigid control cells. Similar responses were obtained with a deletion construct in which sequences upstream of position -1.3 kb had been removed (pColCAT-1.3/1.6), whereas the response with a construct lacking sequences upstream of -0.4 kb (pColCAT-0.4/1.6) was significantly greater (p < 0.01). Taken together, these results indicate that repressor element(s) located in the region between -0.4 and -1.3 kb may dampen the stimulatory effect of mechanical strain. We also tested a construct in which the first intron had been deleted, pColCAT-3.6/0. The response to strain was greater compared with that obtained with construct pColCAT-3.6/1.6 containing the intron, suggesting that the first intron is unlikely to contain important strain response elements and that sequences within the intron may be involved in modulating the magnitude of the transcriptional response.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 1.   Cyclic mechanical strain activates the rat COL1A1 promoter. Serum-starved rat cardiac fibroblasts were transfected with four collagen promoter deletion CAT reporter constructs shown schematically on the left. The -1.6 mark in the full-length construct indicates a region around position -1.6 kb, upstream of the transcription start site, in which a major TAE has previously been reported (18). Dashed lines represent deleted sequences. Angled arrow indicates the transcription start site. The graph on the right shows fold increase in CAT protein levels in response to 48 h of mechanical strain (black bars) over rigid control cells (white bars) for each construct. CAT protein levels in cell lysates were measured by ELISA as described in "Experimental Procedures." Transfection efficiency was controlled for by using the Hirt's assay. Data shown are mean ± S.E. (n = 3 wells) from a representative experiment repeated four times. All constructs displayed a significant increase (p < 0.01) in promoter activity in response to mechanical strain compared with rigid controls as estimated by the Mann-Whitney U test of data from combined experiments.

The data suggest that increased COL1A1 gene expression by mechanical strain is mediated, at least in part, by increased transcription and that regulatory sequences around the transcription start site, within the -0.4/1.6 construct, are involved in mediating this response. In addition, because the pColCAT-3.6/1.6 and pColCAT-1.3/1.6 constructs responded in a similar manner, the only previously reported TGF-beta activation element (TAE) in the rat COL1A1 gene at position -1624 (18) appears not to be involved. This raised two possibilities: either the induction of COL1A1 transcriptional activation by mechanical strain in rat cardiac fibroblasts is independent of TGF-beta or other important TGF-beta response elements, apart from the site reported (18), are present in the rat COL1A1 gene.

TGF-beta Activity Is Increased by Cyclic Mechanical Strain in Cardiac Fibroblasts and Is Necessary for Strain-induced COL1A1 Transcriptional Activation-- To examine whether TGF-beta activity is necessary for strain-induced transactivation of the COL1A1 promoter, we determined the effect of mechanical strain on the activity of a promoter construct lacking the previously described TAE at position -1624 (pColCAT-1.3/1.6) in the presence of a pan-specific TGF-beta neutralizing antibody. Fig. 2A shows that mechanical strain increased activation of the pColCAT-1.3/1.6 construct ~3-fold and that this increase was almost completely blocked in the presence of the antibody. In addition, the activity of this promoter construct was strongly induced by TGF-beta 1 added exogenously as a positive control. Involvement of TGF-beta was further examined by determining levels of total active TGF-beta in the media from mechanically strained and rigid control cells using a TGF-beta bioassay based on Mv1Lu stably transfected with a TGF-beta -responsive PAI-1 promoter luciferase reporter construct (32). PAI-1 promoter activity of these cells in the presence of conditioned medium from mechanically strained cells was 2.6-fold higher compared with medium from rigid control cells (Fig. 2B). These concentrations were equivalent to 30 and 12 pg/ml of active TGF-beta , respectively, extrapolated from a TGF-beta 1 standard curve. Taken together, these results suggest that the induction of the rat COL1A1 promoter by mechanical strain in cardiac fibroblasts requires TGF-beta and that mechanical strain leads to the release of active TGF-beta into the medium. It follows that the COL1A1 promoter activation may be directly mediated by the increase in TGF-beta activity. The finding that the previously reported TAE was not required, further suggests that, in the present study, the transcriptional activation in response to mechanical strain and TGF-beta is mediated through other regions in the promoter and that these regions lie within the pColCAT-0.4/1.6 construct.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Activation of the rat COL1A1 promoter is TGF-beta -dependent. A, CAT protein levels were measured in rigid (white bars) and strained (black bars) cells, which had been transfected with the pColCAT-1.3/1.6 construct (lacks the reported TAE at position -1624, Ref. 18), in the presence (+Ab) or absence (-Ab) of a pan-specific TGF-beta neutralizing antibody. The amount of TGF-beta antibody (75 µg/ml) was such that it neutralized 90% of 1 ng/ml TGF-beta 1 added exogenously as determined by the manufacturer. The same amount of IgG control antibody was added as a negative control. TGF-beta 1 (1 ng/ml) was added to some cells as a positive control for TGF-beta responsiveness of this construct (gray bar). Values presented are the mean relative absorbance units (RAU) ± S.E. from a representative experiment (n = 3 wells). B, conditioned medium from the cells in A was analyzed in a TGF-beta bioassay based on Mv1Lu stably transfected with a TGF-beta -responsive PAI-1 promoter luciferase reporter (32). Data presented are mean ± S.E. luciferase activity expressed as relative light units (RLU). Medium from strained fibroblasts gave a 2.6-fold increase in luciferase activity in Mv1Lu cells, compared with medium from rigid cells (p < 0.01 by Mann-Whitney). These luciferase activities were equivalent to 12 versus 30 pg/ml of TGF-beta 1 in medium from rigid and strained fibroblasts, respectively, as extrapolated from a standard curve from mink lung cells treated with exogenous porcine TGF-beta 1.

Identification of Two Putative Strain Response Regions in the Proximal Promoter-- To delineate mechanical strain response regions in the proximal promoter, constructs with small deletions were generated by sequential 5'-end digestion of the pColCAT-0.4/1.6 construct, which has its 5'-end at position -395 relative to the transcription start site. The relative activities of these promoter constructs, both under basal conditions and in response to mechanical strain, were examined in transient transfection assays. Fig. 3 shows that the longest construct, truncated at position -247, responded strongly to strain (3-fold relative to rigid control) and in a similar fashion to the -395 construct. In contrast, basal activity of the construct truncated at position -197 was about 3.5-fold higher than the two longer constructs and was not further increased in response to strain. Interestingly, the construct truncated at -129 had lower basal activity compared with the -197 construct and also responded significantly to strain. A further deletion that created a construct truncated at position -84, just downstream of a proximal inverted CCAAT-box previously reported to be essential for efficient basal transcription of the mouse COL1A1 gene (38), resulted in very low transcriptional activity and no response to mechanical strain.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Identification of two putative strain response regions in the proximal promoter. A, promoter activity of deletion constructs of the proximal promoter in rigid (white bars) and mechanically strained (black bars) cells. The number under each set of bars indicates the 5'-end position (in base pairs from the transcription start site) of the promoter fragment for that construct. Asterisk denotes a significant increase compared with rigid controls for each construct at p < 0.01 estimated by the Mann-Whitney U test from combined experiments. B, proposed mechanisms of transactivation of the rat COL1A1 promoter under basal condition and during mechanical strain (arrows). Up arrow indicates lifting of repression in Region C and down arrow indicates increased transactivation in Region A by mechanical strain. Angled arrow indicates the transcription start site.

Based on these results, we propose the model illustrated in Fig. 3B as a mechanism for transactivation of the rat COL1A1 promoter by mechanical strain. The region between position -247 and -197 (Region C) contains a strong repressor element, which under basal conditions counteracts a positive element in the region between -197 and -129 (Region B). During mechanical strain the repression in Region C is lifted (indicated by the up-arrow in Fig. 3B) leading to activation of transcription. In addition, a significant portion of the strain response appears to be mediated via sequences downstream of position -129. Taking into account evidence from our initial experiments, which excluded the first intron as containing important region(s) for promoter transactivation in response to mechanical strain (Fig. 1), as well as previously reported studies on basal COL1A1 transcription (see below), we propose that the fragment denoted Region A (-129 to -84) may be involved in mediating the strain response observed using construct -129. Transcriptional activation of the COL1A1 gene by mechanical strain is, therefore, a complex process involving at least two regions (Region A and B/C) in the proximal promoter, which, estimating from the activities of the individual constructs, contribute approximately equally to the response.

In this study we have focused on Region A and explored the possibility that changes in transcription factor binding in this region during mechanical strain is responsible for increased transcriptional activity. Based on previously reported studies on basal COL1A1 promoter regulation and activation by TGF-beta , the region between -129 and -84 (Region A) is of particular interest. It contains an inverted CCAAT-box around position -100 to which either CBF (38) or NF-I (39) can bind. It is flanked by GC-rich binding sites, shown to bind Sp1 (39), or an inhibitory factor designated IF2 (40). The binding of CBF to this site is important for basal COL1A1 promoter activity, as demonstrated by previously reported mutation analyses (38) and more recently for the COL1A2 gene using a dominant-negative form of CBF-A (41). CBF has also been suggested to play a critical role in the coordinate regulation of the two type I procollagen genes (42). Moreover, both NF-I and Sp1, which can act as transactivators at this site, have been implicated in TGF-beta -induced collagen type I gene transcription in other species (43, 44); however, their binding activities at this particular site have not been investigated with respect to TGF-beta stimulation or in response to mechanical strain. Finally, the fact that COL1A1 promoter activation via the mitogen-activated protein kinase (MAPK) ERK1/2 signaling pathway has been mapped to this specific region in activated hepatic stellate cells (45) and that the ERK1/2 pathway can be activated both in response to TGF-beta (46, 47) and mechanical strain (48) lend further support for the involvement of this site in mediating the transcriptional activation of COL1A1 by mechanical strain.

Mechanical Strain and TGF-beta 1 Increases Binding Activity of CBF/NF-Y to the Inverted CCAAT-box in the Proximal Promoter-- To determine which factors bind to Region A, and therefore are potentially involved in promoter activation in response to mechanical strain, EMSAs were performed using nuclear extracts from mechanically strained and rigid rat cardiac fibroblasts (Fig. 4). The oligonucleotides used in these experiments are shown in Fig. 4A and include the Region A oligonucleotide spanning the overlapping inverted CCAAT-box and juxtaposed downstream GC-box described in the previous section. Using this oligonucleotide as a probe, one predominant complex (Complex I) and two weaker broad complexes (Complexes II and III) were detected by EMSA (Fig. 4B). The intensity of the major complex was greater (indicating increased binding activity) using nuclear extracts from both strained cells and cells treated with TGF-beta 1, compared with nuclear extract from rigid control cells (Fig. 4B, left panel). Densitometric quantitation by phosphorimage analysis showed that the intensity of the Complex I band was increased by ~75% in response to both stimuli for 24 h. Furthermore, in parallel with enhanced formation of Complex I, the formation of one of the weaker complexes, Complex III, appeared to be diminished in response to TGF-beta 1 and mechanical strain. This is likely because of either competition for binding at this site between the factors forming Complexes I and III or an actual reduced binding activity of Complex III (e.g. caused by reduced abundance or change in phosphorylation) in response to the two stimuli. Binding specificity and the identity of the factor(s) present in Complex I were further investigated by competition and supershift assays using unlabeled consensus sequence oligonucleotides and specific antibodies to known transcription factors. In competition assays (Fig. 4B, middle panel), a CBF consensus oligonucleotide abolished Complex I formation only, whereas a consensus oligonucleotide for NF-1 diminished Complex II formation. These data are consistent with CBF being present in Complex I. In addition, neither a mutated CBF (CBF mut) oligonucleotide nor a wild-type Sp1 consensus oligonucleotide competed with any of the complexes (Fig. 4B, middle panel). Moreover, when a Region A oligonucleotide with two base pair substitutions in the inverted CCAAT-box (Region A mut) was used as a probe, neither Complex I nor II formed. In contrast, when a CBF consensus oligonucleotide was used as a probe, only Complex I formed (middle panel, far right lane), confirming that Complex I formation involved binding to the CCAAT-box and again, strongly implicating CBF in Complex I formation. To confirm the presence of CBF within Complex I, DNA protein binding assays were performed with specific antibodies. The right panel in Fig. 4B shows that a CBF antibody supershifts Complex I, whereas control IgGs and an antibody to NF-1 have no effect.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 4.   Mechanical strain and TGF-beta 1 increases binding activity of CBF/NF-Y to the inverted CCAAT-box in the proximal promoter. A, upper-strand of double-stranded oligonucleotides used as probes in EMSAs. The Region A oligonucleotide contains the sequence between -119 and -89 of rat COL1A1 according to Lichtler et al. (30) (GenBank accession number J04464). The core binding sites, including the inverted CCAAT-box (italics) are bold, and mutated bases are underlined. B, EMSA of Region A, left panel; left lane shows radioactively labeled Region A oligonucleotide as a probe without nuclear extract in the binding reaction. The following three lanes contain binding reactions with nuclear extracts (3 µg/reaction) from cells that had been rigid, mechanically strained, or treated with 1 ng/ml TGF-beta 1 for 24 h. Complexes formed are denoted Complex I-III. The intensity of the Complex I band was increased by ~75% in response to both stimuli in three separate experiments, one of which is shown here. Middle panel, competition analysis using cold consensus binding site oligonucleotides (as indicated above the lanes) at 125-fold excess and Region A oligonucleotide as probe or Region A mut and CBF oligonucleotides as probes (as indicated below the panel), suggesting that Complex I contains CBF. Right panel, EMSA using specific antibodies against CBF and NF-I and control IgG antibodies as indicated above the panel, and Region A oligonucleotide as probe confirming that Complex I contains CBF.

These results demonstrate that CBF, an activator of COL1A1 transcription, is the predominant factor binding to the inverted CCAAT-box in Region A in rat cardiac fibroblasts. Furthermore, this is the first report showing that binding of CBF to the proximal inverted CCAAT-box in the COL1A1 promoter is enhanced by mechanical strain, as well as by TGF-beta 1, and is consistent with the notion that the strain-induced activation of COL1A1 transcription, at least at this site, is a direct effect of the increase in TGF-beta activity.

A Region A Oligonucleotide Can Confer Strain-induced Transactivation on a Heterologous Promoter-- We further assessed the functional role of the inverted CCAAT-box in Region A in mechanical strain-induced promoter activation by mutation analysis. Because specific mutations in the inverted CCAAT-box within the COL1A1 promoter have been reported to strongly reduce basal transcriptional activity (38), we decided to investigate the functionality of this site by assessing its ability to confer strain response to an otherwise unresponsive heterologous promoter (SV40). The wild-type Region A oligonucleotide (Region A wt) containing the overlapping CCAAT- and GC-boxes used in the EMSAs (Fig. 4) was cloned into the luciferase reporter gene vector pGL2P (Fig. 5B). Fig. 5A shows that promoter activity of this construct was significantly higher in mechanically strained cells, compared with rigid controls, and similar in magnitude to that obtained with construct -129 in which Region A is located within the context of the COL1A1 promoter. In contrast, pGL2P itself did not respond to strain, indicating that the response obtained with the Region A wild-type construct is controlled by sequences within the oligonucleotide itself. Furthermore, a construct containing the Region A oligonucleotide with a mutated CCAAT-box (Figs. 4A and 5B, Region A mut) displayed a significantly reduced strain response (p < 0.01), confirming that factor(s) binding to the CCAAT-box play a significant role in the activation. Although much smaller in magnitude than the response with the wild-type construct, the strain-induced promoter activation observed with the Region A mut construct was still significant. This suggested that factors binding to another site, such as the GC-box, may also contribute to transcriptional activation induced in response to strain, at least under circumstances when there is no binding at the inverted CCAAT-box. To test this, mithramycin, an inhibitor of protein binding to GC-rich sequences, was added to the culture medium. This resulted in an overall reduction in promoter activity of all three constructs, which is likely because of inhibition of protein binding to Sp1 sites (GC-boxes) in the SV40 sequence, known to drive transcription from this promoter. Nevertheless, there was still a significant induction of the activity of the Region A wt construct with mechanical strain, confirming the important contribution by the CCAAT-box in mediating a strain response. In contrast, mithramycin caused a total loss of induction of the Region A mut construct, suggesting that the remaining small activation obtained in response to mechanical strain in the absence of CBF binding is contributed by factors binding to the GC-box in Region A. Because the only binding activity detected by EMSA using the mutated Region A oligonucleotide as a probe is Complex III, which consistently displayed diminished binding during mechanical strain (Fig. 4B, left panel), it is possible that this protein complex contains a transcriptional repressor and that activation may involve lifting of this repression. A model describing transcription factor binding to the Region A sequence, and the effects of mutations in the CCAAT-box and addition of mithramycin (M) on binding, is illustrated in Fig. 5B where R represents the putative repressor binding to the GC-box.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   A Region A oligonucleotide containing the overlapping proximal inverted CCAAT-box and downstream GC-box can confer strain-induced transactivation on a heterologous promoter. A, promoter activity of the pGL2P vector with the wild-type Region A oligonucleotide (wt), mutated Region A oligonucleotide (mut), or pGL2P alone in cells after 30 h of rigid (white bars) or strained (black bars) conditions, with and without 50 nM mithramycin (M). Data presented are from one representative experiment (n = 3 wells) of two repeats, which gave similar results. Asterisk denotes a significant increase compared with rigid controls for each construct/condition at p < 0.01 calculated by the Mann-Whitney U test from combined experiments. In the absence of mithramycin, there was a significant reduction in strain response for the mutated construct compared with the wild type at p < 0.01 by analysis of variance (indicated by the line above the two-strain data bars). B, diagram of heterologous promoter construct (Region A oligonucleotide cloned in front of the SV40 promoter without enhancer in pGL2P) and proposed transcription factor binding to the Region A (wt) sequence (top), the mutated Region A (mut) sequence in the absence (middle), or presence (bottom), of mithramycin (M). R represents an uncharacterized transcription factor, likely to be a repressor, previously designated IF2 (40). CBF and the repressor compete for binding at this site, with CBF having higher affinity. Crosses denote inhibition of binding, either to the CCAAT-box by mutations or to the GC-box by mithramycin.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Enhanced type I collagen expression plays an important role in driving excessive matrix deposition in a number of fibrotic disorders. Despite a long-established correlation between increased mechanical strain on tissues and extracellular matrix accumulation, and more recent in vitro studies confirming a direct link, very little is known about the underlying mechanisms of this phenomenon. The present study begins to elucidate a complex regulation of the COL1A1 gene by mechanical strain by demonstrating for the first time that strain-induced transcriptional activation in cardiac fibroblasts is: (a) dependent on the release of active TGF-beta , (b) mediated by at least two regions in the proximal promoter, and (c) involves increased binding of CBF to an inverted CCAAT-box.

The activation of TGF-beta by mechanical forces has been demonstrated previously in a number of cell types, including mesangial cells (49) and cardiac fibroblasts (17). Because TGF-beta is the most potent activator of collagen gene expression identified to date (4), there is a strong possibility that the induction of collagen transcription by mechanical stress is mediated through the autocrine stimulation by TGF-beta . Hori et al. (15) provided experimental evidence that this is the case in mesangial cells, and were supported by a subsequent study of intestinal smooth muscle cells (16). With the results presented here, obtained with cardiac fibroblasts, it is now evident that a mechanism of mechanical strain-induced COL1A1 expression dependent on autocrine TGF-beta stimulation exists for a wide range of mesenchymal cells. There are several mechanisms by which active TGF-beta may contribute to the strain-induced activation of COL1A1 transcription observed. First, the increase in COL1A1 promoter activity may be directly caused by the increase in TGF-beta activity and, therefore, involve a novel TGF-beta response element in the COL1A1 gene. Second, TGF-beta may have a permissive function and contribute indirectly by providing a cell-signaling pathway (e.g. by stimulating the synthesis of a signaling molecule) without which strain-induced activation of the COL1A1 gene cannot occur. Such synergistic effects have been observed in several recent studies, for example, those involving intracellular signals from growth factor receptors and integrins (50). Given the recognized effect of TGF-beta on COL1A1 transcription, combined with our findings that the proximal inverted CCAAT-box mediates strain-induced transcriptional activation, and that TGF-beta alone can cause increased binding activity of CBF at this site, it is highly likely that, at least at this site, the COL1A1 transcriptional activation by mechanical strain is a direct effect of TGF-beta stimulation.

A major TGF-beta activation element has previously been identified by Ritzenthaler et al. (18) at position -1624 in the rat COL1A1 gene. It is, therefore, of interest that in our study mechanical strain did not require this TGF-beta response element. The reason for this apparent discrepancy is not clear; however, some differences in the experimental model between our study and that of Ritzenthaler et al. may be significant, for example, the choice of cell-type. We used the rat promoter constructs transfected into rat cardiac fibroblasts, whereas Ritzenthaler et al. used human embryonic lung fibroblasts (IMR-90). Another difference between the two studies, which may be a more likely cause of the discrepancy, is the fact that we employed promoter constructs containing the first intron of the gene. The first intron has been shown to contain important repressor elements (36), and it is therefore possible that in our experiments the TAE at position -1624 is counteracted by these repressor elements. The original study by Ritzenthaler et al. (18), although demonstrating a dramatic decrease in promoter activation in response to TGF-beta by deleting the TAE, provided some evidence for the existence of additional response elements because the response was still ~2-fold in the absence of the TAE. These observations were subsequently confirmed by a second independent study by King et al. (20) employing rat lung fibroblasts. Interestingly, a recent in vivo study by the group originally reporting the TAE, using transgenic mice carrying 3.6 kb of the rat COL1A1 promoter gene with or without mutations in the TAE, has provided evidence that questions the critical role of this site (19). In this study, both the wild-type and mutated constructs showed a similar up-regulation of reporter gene expression during bleomycin-induced fibrosis, which is mediated in part by TGF-beta , supporting the notion that other important TGF-beta response elements exist in the rat COL1A1 promoter.

Previously reported studies mapping TGF-beta response elements in the two type I collagen genes from different species collectively suggest that the regulation is complex, involving diverse transcription factors binding to several distinct sites (21, 43, 44, 51, 52). Results from our study strongly suggest that the site comprising the proximal inverted CCAAT-box and adjacent GC-box around position -100 is one of the so far unidentified TGF-beta response elements in the rat COL1A1 gene. The predominant factor shown to bind to this site, CBF (also known as NF-Y or CP1), is a ubiquitous transcription factor important for efficient basal transcription of several mammalian genes containing CCAAT-box elements, including the serum albumin and major histocompatibility complex class II genes (53). It acts by disrupting the nucleosome structure (54) and cooperatively interacts with promoter-specific transcription factors to activate transcription (53, 55). More recent studies have shown that CBF also plays a role in regulating a number of genes during conditions of cellular stress, for example, in the activation of the multiple drug resistance gene MDR1 by UV radiation (56), and activation of the tissue inhibitor of the metalloproteinases-2 (TIMP-2) gene in response to cAMP (57). A specific role for CBF in the induction of COL1A1 transcription had not previously been investigated. Our findings that CBF binding activity is increased during mechanical strain, and in response to TGF-beta 1, in cardiac fibroblasts are novel and suggest a wider role for CBF in regulating type I collagen expression. A recent report published during the course of this study supports this notion by demonstrating increased binding activity of CBF in dermal fibroblasts from patients with systemic sclerosis (58), a multisystem fibrotic disorder in which TGF-beta has been strongly implicated. Moreover, in a recent study performed in our laboratory using microarray technology, mRNA levels of CBF-C, one of the three CBF subunits, were increased 4.6-fold in fibroblasts exposed to TGF-beta 1 compared with untreated controls,2 demonstrating a direct link between TGF-beta signaling and CBF regulation. A detailed study of the induction of the CBF subunits in response to TGF-beta is in progress in our laboratory.

In our experiments, investigating a functional role for Region A in a heterologous promoter construct, a second factor(s) (Complex III), binding to the GC-box immediately downstream of the inverted CCAAT-box, also appeared to be involved in the mechanical strain response. The fact that its binding activity demonstrated in EMSA is consistently reduced in response to mechanical strain and TGF-beta (Fig. 4B), suggests that this factor may be a repressor. The identity of this factor is currently unknown, although Sp1 or Sp3 could be excluded because an Sp1 consensus oligonucleotide was unable to compete with its binding in EMSA. Another likely possibility is the repressor IF2, previously reported by Karsenty and de Crombrugghe (40). However, antibodies to this factor are not commercially available. The small but significant contribution from the GC-box to strain-induced transcriptional activation suggests a functional involvement of this site. However, this observation was made in the absence of binding of CBF to the CCAAT-box (i.e. using the Region A mut construct). Competitive and mutually exclusive binding to these two overlapping sites has been demonstrated together with a higher binding affinity of CBF for the CCAAT-box (59). Because CBF is the predominant factor binding to this site in the experimental conditions used here, we propose that the major contribution from this element to the mechanical strain response is attributed to the increased binding of CBF to the inverted CCAAT-box. We also suggest that the reduction in binding activity of Complex III observed in the EMSA in response to TGF-beta and mechanical strain is because of competition by the increase in CBF binding. Further experiments, however, will be required to firmly exclude an involvement of the GC-box and Complex III in mechanical strain-induced COL1A1 promoter activation.

This study also identified a more distal region in the proximal promoter (Region B/C), which appears to be involved in the mechanical strain response and which, therefore, may also contain a TGF-beta activation element. Previous results from studies of basal regulation are in accordance with our proposed model of mechanical strain activation in this region (Fig. 3B). A repressor element, known to bind cKrox (60) or BFCOL-1 (61) under basal conditions, has been mapped to the sequence spanning the junction between regions in the mouse gene equivalent to Regions B and C. However, the role of this element in regulating COL1A1 transcription during cellular stress and in response to TGF-beta has not been evaluated. Furthermore, in rat cardiac fibroblasts a strong positive element has been mapped to Region B under basal conditions, and an upstream repressor has been suggested to counteract the effect of this positive element (62). Our data agree with this because the reported repressor element would be disrupted in the -197 construct and give rise to high basal levels. Furthermore, if the repression is alleviated by mechanical strain, this may explain the increase in activity in response to strain observed with the -247 construct, as well as the lack of increase of the already high activity seen with the -197 construct. Moreover, in a study by Jimenez et al. (51), a region in the human gene equivalent to the region containing the positive element identified in the rat gene (Region B) was shown to contain a TGF-beta response element. The factors binding at this site have not been characterized, and although there are areas of significant sequence homology between species in this region, TGF-beta responsiveness at this site has not been evaluated in the murine or rat COL1A1 genes. A detailed study is currently underway to characterize transcription factor binding in this region of the rat COL1A1 gene during stimulation by mechanical strain and in response to TGF-beta .

In summary, this study demonstrates that activation of the rat COL1A1 gene by mechanical strain involves at least two regions within the proximal promoter. Our data further suggest that this response is TGF-beta -dependent and involves increased binding of the ubiquitous transcription factor CBF at the proximal inverted CCAAT-box element. Based on these findings, and the fact that functional CBF-binding sites in both COL1A1 and COL1A2 genes are highly conserved between species, we propose that CBF may play an important role in the up-regulation of type I collagen expression in response to cellular stresses mediated by TGF-beta stimulation. Overexpression of the type I collagen genes is believed to be a key event leading to excess deposition of extracellular matrix in tissue fibrosis. A closer investigation of the role of CBF in fibrotic conditions is therefore warranted.

    ACKNOWLEDGEMENTS

We thank A. Lichtler and D. Rowe for kindly providing the parent rat COL1A1 promoter reporter construct and D. Rifkin for permission to use the stably transfected Mv1Lu cells. We are also grateful to J. Norman, Center for Nephrology and Urology, Department of Medicine, Royal Free and University College Medical School (RFUCLMS) for helpful discussions and critical review of the manuscript and J. Palmen, Cardiovascular Genetics, Department of Medicine (RFUCLMS) for help with DNA sequencing.

    FOOTNOTES

* This work was supported by The Wellcome Trust Program Grant 051154, The Wellcome Trust Project Grant 044502, and the Royal Free and University College Medical School.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Tel.: 44-207-679-6976; Fax: 44-207-679-6973; E-mail: g.lindahl@ucl.ac.uk.

Published, JBC Papers in Press, December 17, 2001,DOI 10.1074/jbc.M108966200

2 R. C. Chambers, personal communication.

    ABBREVIATIONS

The abbreviations used are: TGF-beta , transforming growth factor-beta ; CBF/NF-Y, CCAAT-binding factor; TAK1, transforming-growth factor beta -activated kinase; CAT, chloramphenicol acetyl transferase; ELISA, enzyme-linked immunosorbent assay; PAI-1, plasminogen activator inhibitor-1; EMSA, electrophoresis mobility shift assays; TAE, TGF-beta activation element; wt, wild type.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Bishop, J. E., and Lindahl, G. (1999) Cardiovasc. Res. 42, 27-44[CrossRef][Medline] [Order article via Infotrieve]
2. Watson, P. A. (1991) FASEB J. 5, 2013-2019[Abstract]
3. Liu, M., Tanswell, A. K., and Post, M. (1999) Am. J. Physiol. 277, L667-L683
4. Chambers, R. C., and Laurent, G. J. (1997) in The Lung: Scientific Foundations (Crystal, R. D. , West, J. B. , Weibel, E. R. , and Barnes, P. J., eds) , pp. 709-727, Lippincott-Raven, Philadelphia
5. McAnulty, R. J., and Laurent, G. J. (1995) in Pulmonary Fibrosis (Phan, S. H. , and Thrall, R. S., eds) , pp. 135-171, Marcel Dekker, Inc., New York
6. Varga, J., and Jimenez, S. A. (1995) Ann. Intern. Med. 122, 60-62[Abstract/Free Full Text]
7. Trojanowska, M., Leroy, E. C., Eckes, B., and Krieg, T. (1998) J. Mol. Med. 76, 266-274[CrossRef][Medline] [Order article via Infotrieve]
8. Slack, J. L., Liska, D. J., and Bornstein, P. (1993) Am. J. Med. Genet. 45, 140-151[CrossRef][Medline] [Order article via Infotrieve]
9. Karsenty, G., and Park, R. W. (1995) Int. Rev. Immunol. 12, 177-185[Medline] [Order article via Infotrieve]
10. O'Kane, S., and Ferguson, M. W. (1997) Int. J. Biochem. Cell Biol. 29, 63-78[CrossRef][Medline] [Order article via Infotrieve]
11. Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., and Gauldie, J. (1997) J. Clin. Invest. 100, 768-776[Abstract/Free Full Text]
12. Lijnen, P. J., Petrov, V. V., and Fagard, R. H. (2000) Mol. Genet. Metab. 71, 418-435[CrossRef][Medline] [Order article via Infotrieve]
13. Zhang, D., Gaussin, V., Taffet, G. E., Belaguli, N. S., Yamada, M., Schwartz, R. J., Michael, L. H., Overbeek, P. A., and Schneider, M. D. (2000) Nat. Med. 6, 556-563[CrossRef][Medline] [Order article via Infotrieve]
14. Butt, R. P., and Bishop, J. E. (1997) J. Mol. Cell Cardiol. 29, 1141-1151[CrossRef][Medline] [Order article via Infotrieve]
15. Hori, Y., Katoh, T., Hirakata, M., Joki, N., Kaname, S., Fukagawa, M., Okuda, T., Ohashi, H., Fujita, T., Miyazono, K., and Kurokawa, K. (1998) Kidney Int. 53, 1616-1625[CrossRef][Medline] [Order article via Infotrieve]
16. Gutierrez, J. A., and Perr, H. A. (1999) Am. J. Physiol. 277, G1074-G1080[Abstract/Free Full Text]
17. Lee, A. A., Delhaas, T., McCulloch, A. D., and Villarreal, F. J. (1999) J. Mol. Cell Cardiol. 31, 1833-1843[CrossRef][Medline] [Order article via Infotrieve]
18. Ritzenthaler, J. D., Goldstein, R. H., Fine, A., Lichtler, A., Rowe, D. W., and Smith, B. D. (1991) Biochem. J. 280, 157-162
19. Stoddart, J. H., Jr., Ladd, D., Bronson, R. T., Harmon, M., Jaworski, J., Pritzker, C., Lausen, N., and Smith, B. D. (2000) J. Cell. Biochem. 77, 135-148[CrossRef][Medline] [Order article via Infotrieve]
20. King, S. L., Lichtler, A. C., Rowe, D. W., Xie, R., Long, G. L., Absher, M. P., and Cutroneo, K. R. (1994) J. Biol. Chem. 269, 13156-13161[Abstract/Free Full Text]
21. Chen, S. J., Yuan, W., Mori, Y., Levenson, A., Trojanowska, M., and Varga, J. (1999) J. Invest Dermatol. 112, 49-57[CrossRef][Medline] [Order article via Infotrieve]
22. Massague, J., and Wotton, D. (2000) EMBO J. 19, 1745-1754[CrossRef][Medline] [Order article via Infotrieve]
23. Zhang, W., Ou, J., Inagaki, Y., Greenwel, P., and Ramirez, F. (2000) J. Biol. Chem. 275, 39237-39245[Abstract/Free Full Text]
24. Poncelet, A. C., and Schnaper, H. W. (2001) J. Biol. Chem. 276, 6983-6992[Abstract/Free Full Text]
25. Qing, J., Zhang, Y., and Derynck, R. (2000) J. Biol. Chem. 275, 38802-38812[Abstract/Free Full Text]
26. Roberts, A. B., Piek, E., Bottinger, E. P., Ashcroft, G., Mitchell, J. B., and Flanders, K. C. (2001) Chest 120, 43S-47S
27. Butt, R. P., Laurent, G. J., and Bishop, J. E. (1995) Eur. J. Cell Biol. 68, 330-335[Medline] [Order article via Infotrieve]
28. Ono, S., Waldman, L. K., Yamashita, H., Covell, J. W., and Ross, J., Jr. (1995) Circulation 91, 1143-1153[Medline] [Order article via Infotrieve]
29. Breault, D. T., Lichtler, A. C., and Rowe, D. W. (1997) J. Biol. Chem. 272, 31241-31250[Abstract/Free Full Text]
30. Lichtler, A., Stover, M. L., Angilly, J., Kream, B., and Rowe, D. W. (1994) J. Biol. Chem. 269, 16518[Free Full Text]
31. Clark, I. M., Rowan, A. D., Edwards, D. R., Bech-Hansen, T., Mann, D. A., Bahr, M. J., and Cawston, T. E. (1997) Biochem. J. 324, 611-617
32. Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskutoff, D. J., and Rifkin, D. B. (1994) Anal. Biochem. 216, 276-284[CrossRef][Medline] [Order article via Infotrieve]
33. Schreiber, E., Matthias, P., Muller, M. M., and Schaffner, W. (1989) Nucleic Acids Res. 17, 6419[Free Full Text]
34. Wade, D. P., Lindahl, G. E., and Lawn, R. M. (1994) J. Biol. Chem. 269, 19757-19765[Abstract/Free Full Text]
35. Raisz, L. G., Fall, P. M., Petersen, D. N., Lichtler, A., and Kream, B. E. (1993) Mol. Endocrinol. 7, 17-22[Abstract]
36. Bornstein, P. (1996) Matrix Biol. 15, 3-10[CrossRef][Medline] [Order article via Infotrieve]
37. Chen, A., and Davis, B. H. (2000) Mol. Cell. Biol. 20, 2818-2826[Abstract/Free Full Text]
38. Maity, S. N., Golumbek, P. T., Karsenty, G., and de Crombrugg